Primary endpoint: composite of cardiovascular death, myocardial infarction, or ischemic stroke (94), composite of death from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke (95), composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for unstable angina (96), or time to first occurrence of the composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke (97), respectively
The Structural Basis for Semaglutide's Enhanced Stability Semaglutide's superior stability compared to native GLP-1 is not accidental
The prefilled pen delivers accurate doses without requiring patients to measure volumes or perform conversions
They contain proanthocyanidins that prevent bacteria from adhering to the urinary tract lining
5 mg Dose: Draw 50 units (0.5 mL)